Scoping Review: The Role of Psychedelics in the Management of Chronic Pain
Christopher L. Robinson, Alexandra Fonseca, Efemena Diejomaoh, Ryan S. D’souza, Michael E Schatman, Vwaire Orhurhu, Trent Emerick
Journal of Pain Research March 1, 2024 DOI: 10.2147/jpr.s439348 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Randomized Placebo-controlled Double-blind Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Chronic pain Medline Hallucinogen |
| Citations | 32 |
| Key findings | Psychedelics may have potential in alleviating pain symptoms secondary to a multitude of chronic pain conditions, but further randomized, double-blind, placebo-controlled trials are needed. |
Abstract
Psychedelics may have potential in alleviating pain symptoms secondary to a multitude of chronic pain conditions. However, further randomized, double-blind, placebo-controlled trials are needed to further explore and evaluate the role of psychedelics in chronic, non-cancer pain.